Related Experiment Video
Updated: Aug 6, 2026
Quantitative Measurement of Intrathecally Synthesized Proteins in Mice
Published on: November 29, 2019
Reduced serum IL-6 as a potential peripheral marker of amnestic mild cognitive impairment: A pilot study
María Micaela Castro1, Romina Alejandra Pavón2, Alejandro David Moroni1
1Centro de Investigaciones Básicas y Aplicadas, Universidad Nacional Del Noroeste de la Provincia de Buenos Aires, Jorge Newbery 261, Junín, Buenos Aires (B6000), Argentina; Centro de Investigaciones y Transferencia Del Noroeste de La Provincia de Buenos Aires (CITNOBA) - UNNOBA-UNSAdA-CONICET, Monteagudo 2772, Pergamino, Buenos Aires (B2700), Argentina.
Introduction And Objective:
Mild cognitive impairment (MCI) represents an intermediate state between age-related cognitive changes and early stages of dementia. People with amnestic subtype (aMCI) show higher risks of progression to dementia due to Alzheimer's disease. In this pilot study, the aim was to investigate whether cytokines could be potential peripheral markers associated with MCI.
Methods:
Women were recruited in Junín city, Buenos Aires, Argentina. Their cognitive performance was evaluated using a neuropsychological battery. Serum levels of IFN-γ, IL-1β, IL-2, IL-4 and IL-6 were analyzed by ELISA, and the type 2/type 1 balance was determined. Correlations between both parameters, as well as within-group analysis cytokines levels were evaluated.
Results:
After cognitive evaluation, participants were classified as healthy controls (HC: n=14) or as aMCI (n=7). IL-6 levels were significantly decreased in the aMCI group compared with HC (p=0.047). IFN-γ showed no robust correlations within the HC group but presented a strong negative correlation with IL-2 (p=0.005) and IL-4 (p=0.052) in aMCI. Several correlations were found between cytokine levels, the type 2/type 1 balance and neurocognitive tests.
Conclusions:
We concluded that IL-6 decreased levels, altered correlation in cytokine profiles, together with performance on the neuropsychological battery, may serve as potential blood-markers of amnestic mild cognitive impairment.